Bogdana Schmidt, MD, MPH, shares why gemcitabine intravesical system is a game changer in NMIBC
Автор: Urology Times
Загружено: 2025-09-18
Просмотров: 207
Описание:
Bogdana Schmidt, MD, MPH, discusses the recently FDA-approved gemcitabine intravesical system (Inlexzo; formerly TAR-200) for adult patients with BCG-unresponsive non–muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors.
For more, see https://www.urologytimes.com/view/fda...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: